Analyst Price Targets — CV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 4, 2025 9:17 am | — | Roth Capital | $7.00 | $4.78 | TheFly | CapsoVision resumed with a Buy at Roth Capital |
| July 28, 2025 8:32 am | Jason Wittes | Roth Capital | $6.00 | $4.00 | TheFly | CapsoVision initiated with a Buy at Roth Capital |
| May 30, 2024 11:17 am | James Quigley | Raymond James | $156.00 | $0.00 | Benzinga | Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead: Goldman Sachs |
Latest News for CV
CapsoVision (NASDAQ: CV - Get Free Report) and Nanovibronix (NASDAQ: FEED - Get Free Report) are both small-cap manufacturing companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk. Profitability This table compares CapsoVision and Nanovibronix's net…
CapsoVision, Inc. (CV) Q4 2025 Earnings Call Transcript
Reports Preliminary, Unaudited Fourth-Quarter and Full Year 2025 Financial Results Reports Preliminary, Unaudited Fourth-Quarter and Full Year 2025 Financial Results
SARATOGA, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the company will release fourth quarter and full year 2025 financial results on Thursday, March 26, 2026, after the close of market.
CapsoVision (NASDAQ: CV - Get Free Report) and Biosig Technologies (NASDAQ: STEX - Get Free Report) are both small-cap manufacturing companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability. Profitability This table compares CapsoVision and Biosig…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CV.
U.S. House Trading
No House trades found for CV.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.